Skip to Primary Content

Publix follows guidance and suspends administration of Johnson & Johnson COVID-19 vaccine

LAKELAND, Fla., April 13, 2021 — Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

Customers can visit to schedule an appointment for the Moderna COVID-19 vaccine, if currently available in their state.

The CDC and FDA have issued a joint media statement with additional information about the Johnson & Johnson COVID-19 vaccine. According to the CDC and FDA, while a rare side effect, individuals who have received the Johnson & Johnson COVID-19 vaccine should contact their health care provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination.


* Subject to Publix’s Media Use Policy. Editorial use only. Content remains the property of Publix and
  will be removed in Publix’s discretion. All rights reserved. Download all images*

Asset Description Download Link
Publix pharmacy logo Download*
Publix pharmacy logo Download*
Publix pharmacy logo Download*